114 related articles for article (PubMed ID: 7571023)
1. Clinical utility of radioimmunoscintigraphy of non-Hodgkin's lymphoma with radiolabelled LL2 monoclonal antibody, LymphoSCAN: preliminary results.
Gasparini M; Bombardieri E; Tondini C; Maffioli L; Hughes L; Burraggi GL; Goldenberg DM
Tumori; 1995; 81(3):173-8. PubMed ID: 7571023
[TBL] [Abstract][Full Text] [Related]
2. Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragment.
Blend MJ; Hyun H; Kozloff M; Levi H; Mills GQ; Gasparini M; Buraggi G; Hughes L; Pinsky CM; Goldenberg DM
Cancer Res; 1995 Dec; 55(23 Suppl):5764s-5770s. PubMed ID: 7493343
[TBL] [Abstract][Full Text] [Related]
3. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas.
Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G
Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma imaging with a new technetium-99m labelled antibody, LL2.
Murthy S; Sharkey RM; Goldenberg DM; Lee RE; Pinsky CM; Hansen HJ; Burger K; Swayne LC
Eur J Nucl Med; 1992; 19(6):394-401. PubMed ID: 1618230
[TBL] [Abstract][Full Text] [Related]
5. 67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma.
Becker WS; Behr TM; Cumme F; Rössler W; Wendler J; Kern PM; Gramatzki M; Kalden JR; Goldenberg DM; Wolf FG
Cancer Res; 1995 Dec; 55(23 Suppl):5771s-5773s. PubMed ID: 7493344
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m LL-2 Fab' monoclonal antibody imaging in acquired immune deficiency syndrome-related lymphoma.
Kramer EL; Volm M; Donahue B; Wasserheit C; Chapnick J; Sanger J; Koslow M
Cancer; 1997 Dec; 80(12 Suppl):2469-77. PubMed ID: 9406697
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunodetection of Hodgkin's disease and non-Hodgkin's lymphomas with monoclonal antibody to eosinophil peroxidase.
Samoszuk MK; Anderson AL; Ramzi E; Wang F; Braunstein P; Lutsky J; Majmundar H; Slater LM
J Nucl Med; 1993 Aug; 34(8):1246-53. PubMed ID: 8326380
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL).
Lamonica D; Czuczman M; Nabi H; Klippenstein D; Grossman Z
Cancer Biother Radiopharm; 2002 Dec; 17(6):689-97. PubMed ID: 12537673
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphoma.
Vervoordeldonk SF; Heikens J; Goedemans WT; Merle PA; von dem Borne AE; van Royen EA; Slaper-Cortenbach IC; van Oers RH
Cancer Immunol Immunother; 1996 Jun; 42(5):291-6. PubMed ID: 8706051
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
13. Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin's lymphoma and diffuse bone marrow uptake.
Juweid M; Sharkey RM; Siegel JA; Behr T; Goldenberg DM
Cancer Res; 1995 Dec; 55(23 Suppl):5827s-5831s. PubMed ID: 7493354
[TBL] [Abstract][Full Text] [Related]
14. Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas.
Nuutinen J; Leskinen S; Lindholm P; Söderström KO; Någren K; Huhtala S; Minn H
Eur J Nucl Med; 1998 Jul; 25(7):729-35. PubMed ID: 9662595
[TBL] [Abstract][Full Text] [Related]
15. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
Chajari M; Lacroix J; Peny AM; Chesnay E; Batalla A; Henry-Amar M; Delcambre C; Génot JY; Fruchard C; Bardet S
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):380-7. PubMed ID: 12002715
[TBL] [Abstract][Full Text] [Related]
16. 99Tcm-LL1: a potential new bone marrow imaging agent.
Juweid M; Dunn RM; Sharkey RM; Rubin AD; Hansen HJ; Goldenberg DM
Nucl Med Commun; 1997 Feb; 18(2):142-8. PubMed ID: 9076770
[TBL] [Abstract][Full Text] [Related]
17. Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.
Goldenberg DM; Horowitz JA; Sharkey RM; Hall TC; Murthy S; Goldenberg H; Lee RE; Stein R; Siegel JA; Izon DO
J Clin Oncol; 1991 Apr; 9(4):548-64. PubMed ID: 2066752
[TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy in Hodgkin's disease and anaplastic large cell lymphomas: results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3.
da Costa L; Carde P; Lumbroso JD; Ricard M; Pfreundschuh M; Bosq J; Manil L; Diehl V; Parmentier C
Ann Oncol; 1992 Sep; 3 Suppl 4():53-7. PubMed ID: 1333272
[TBL] [Abstract][Full Text] [Related]
19. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
Gratz S; Behr T; Herrmann A; Dresing K; Tarditi L; Franceschini R; Rhodes B; Stürmer KM; Becker W
Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
